News | Chronic pain

News

Antidepressants largely ineffective for back pain and osteoarthritis

Researchers have concluded that the benefit of antidepressants for back pain and osteoarthritis is “very limited”.…

Published: 3 March 2021

Opinion

Gillian Leng: ‘COVID-19 has been a strain, but also an opportunity’

The National Institute for Health and Care Excellence’s new chief executive, Gillian Leng, took the helm in April 2020, during the first COVID-19 lockdown. She speaks to us about what lessons the organisation has taken away from the past year.…

Published: 30 December 2020

Feature

Gillian Leng: ‘COVID-19 has been a strain, but also an opportunity’

The National Institute for Health and Care Excellence’s new chief executive, Gillian Leng, took the helm in April 2020. She speaks to us about what lessons the organisation has taken away from the past year.…

Published: 30 December 2020

Opinion

How our multidisciplinary approach helped us reduce our practice’s high-dose prescribing by almost half

Senior GP pharmacist Rory Donnelly explains how his practice helped reduce high-dose opioid prescribing by an average of 40%.…

Published: 17 December 2020

Opinion

Medical cannabis has yet to live up to the hype

Two years since legalisation, prescribers need convincing that medical cannabis is an effective therapy option.…

Published: 27 November 2020

News

Fremanezumab safe and effective for preventing migraine over longer term, study suggests

Patients with migraine continue to benefit from preventive treatment with fremanezumab over the longer term, with sustained reductions in monthly migraine and headache days, a study in Neurology has suggested.…

Published: 11 November 2020

News

Healthcare professionals must warn patients of opioid dependence risk, advises medicines regulator

Healthcare professionals should warn patients taking opioids of their risk of dependence and addiction, the Medicines and Healthcare products Regulatory Agency has advised.…

Published: 24 September 2020

News

‘Deep concern’ over ‘not fit for purpose’ draft NICE guidance on chronic pain

Experts in pain medicine have said they are “deeply concerned” with the “confusing” terminology used in the National Institute for Health and Care Excellence’s draft guidance on chronic pain.…

Published: 15 September 2020

News

Aspirin, paracetamol and ibuprofen should not be prescribed for chronic pain syndromes, NICE draft guidance says

Common pain medicines, such as paracetamol, aspirin and ibuprofen, should not be offered to patients with chronic primary pain, according to National Institute for Health and Care Excellence draft guidance. …

Published: 4 August 2020

News

Draft NICE guidance advises against the use of gabapentinoids and benzodiazepines for sciatica

Gabapentinoids, oral corticosteroids and benzodiazepines should not be offered to patients with sciatica, according to the National Institute for Health and Care Excellence.…

Published: 20 July 2020